This case reports on a 76-year-old male patient, who was admitted to the emergency department two weeks after an elective and initially complication-free pancreas resection with acute abdomen, signs of shock, and progressive somnolence. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-patient-with-septic-shock-after-anastomosis-insufficiency-with-abscess-following-pancreatic-resection_compressed.pdf" title="Use of CytoSorb in a patient with septic shock after anastomosis insufficiency with..
Read More
This case study reports on a 59-year-old patient who presented with dyspnea and weight gain of 12 kg at a peripheral hospital. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-patient-with-mitral-valve-dysfunction-atypical-pneumonia-and-mixed-cardiogenic-and-septic-shock_compressed.pdf" title="Use of CytoSorb in a patient with mitral valve dysfunction, atypical pneumonia and mixed cardiogenic and septic shock_compressed"]
Read More
This case reports on a 58-year-old male patient who was admitted to the South Munich Surgical Clinic for urgent coronary artery bypass surgery. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Ticagrelor-and-Rivaroxaban-Elimination-With-CytoSorb-Adsorber-Before-Urgent-Off-Pump-Coronary-Bypass-_compressed.pdf" title="Ticagrelor and Rivaroxaban Elimination With CytoSorb Adsorber Before Urgent Off-Pump Coronary Bypass _compressed"]
Read More
This case reports on a 23-year-old male patient, who was admitted to the hospital with complaints of dyspnea associated with tiredness, dizziness and chest discomfort. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Use-of-CytoSorb-in-a-patient-undergoing-orthotopic-heart-transplant-surgery-_compressed.pdf" title="Use of CytoSorb in a patient undergoing orthotopic heart transplant surgery _compressed"]
Read More
El uso intraoperatorio de CytoSorb en pacientes sometidos a tratamiento con ticagrelor o rivaroxaban que tienen que someterse a una cirugía de emergencia a corazón abierto es un método seguro y eficaz para reducir las complicaciones hemorrágicas y mejorar el resultado postoperatorio. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Reducir-el-riesgo-de-hemorragia-perioperatoria-en-pacientes-con-ticagrelor-rivaroxaban_compressed-1.pdf" title="Reducir el riesgo de hemorragia..
Read More
Con el uso de Cytosorb los datos clínicos actuales apuntan claramente a una estabilización rápida de la hemodinamia y las funciones orgánicas de los pacientes de cuidados intensivos con síndrome de hiperinflamación aguda. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Terapia-CytoSorb_compressed.pdf" title="Terapia CytoSorb_compressed"]
Read More
The intraoperative use of the CytoSorb hemoadsorption in patients with ticagrelor or rivaroxaban treatment undergoing emergency open-heart operations is a safe and effective method to reduce bleeding complications and to improve the postoperative outcome. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Reduce-peri-operative-bleeding-risk-in-patients-on-ticagrelorrivaroxaban_compressed.pdf" title="Reduce peri-operative bleeding risk in patients on ticagrelor:rivaroxaban_compressed"]
Read More
Ticagrelor is a platelet aggregation inhibitor and is recommended in the current European Guidelines for the treatment of acute coronary syndrome and prevention of stent thrombosis. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Reduce-bleeding-complications-in-patients-on-ticagrelor_compressed.pdf" title="Reduce bleeding complications in patients on ticagrelor(_compressed"]
Read More
El ticagrelor es un inhibidor de la agregación plaquetaria y se recomienda en las directrices europeas para el tratamiento del síndrome coronario agudo y para la profilaxis de la trombosis del stent coronario. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Reducción-de-complicaciones-hemorrágicas-en-pacientes-sometidos-a-tratamiento-con-ticagrelor_compressed.pdf" title="Reducción de complicaciones hemorrágicas en pacientes sometidos a tratamiento con ticagrelor_compressed"]
Read More
This case study reports on a 69-year-old female patient (pre-existing medical conditions: chronic heart failure NYHA III, Type 2 diabetes mellitus, multiple myeloma, chronic kidney disease stage 3), who was admitted from another university hospital for cardiac surgery, after she was diagnosed with septic endocarditis, mitral regurgitation (4th degree) and..
Read More